Sunday, August 16, 2026
20.8
C
Bengaluru
Hot topics
Indian Pharma – The Emerging Role of Hybrid Sales Model
COVID-19 has accelerated the shift in how pharma was engaging with HCPs, professional organisations and even patients in India from a sales to more of a scientific, unbiased and balanced marketing communications. As one of the business leader from a prominent MNC said, “For the first time we are seeing a certain shift in HCP’s preference for scientific communication for innovators companies. MSLs and scientific operation teams will be playing a key role in the near future.”
Pharma GCCs – What Used to Happen in Boston or Basel Now Happens in Bangalore
GCCs - Indian Pharma moves up the Value Chain...
Healthcare Isn’t Working As Well As It Should – A Brief Summary Of The ZS Report 2024
The ZS report discusses how people feel about healthcare...
Will President Trump’s Diktat Improve Drug Quality For Indian Patients?
Executive Summary
The geopolitical landscape of pharmaceutical manufacturing is shifting...
Mounjaro is the Exceptional Growth Story: Ranks #1
The July Brand Monitor by Pharmarack shows a healthy...
Sun Pharma: In the Eye of the Storm of Ophthalmologists
The Two-Tier Reality of Indian Pharma: Patient Safety, Pharmacovigilance,...
Kailash Joshi has been appointed as Executive Director – Analytics, Insights & Decision Enablement (US) at Novartis, as part of the Novartis Global Capability...
With extensive experience across commercial excellence, analytics, insights, AI-driven...
Will President Trump’s Diktat Improve Drug Quality For Indian Patients?
Executive Summary
The geopolitical landscape of pharmaceutical manufacturing is shifting...
Mounjaro is the Exceptional Growth Story: Ranks #1
The July Brand Monitor by Pharmarack shows a healthy...
Sun Pharma: In the Eye of the Storm of Ophthalmologists
The Two-Tier Reality of Indian Pharma: Patient Safety, Pharmacovigilance,...
Kailash Joshi has been appointed as Executive Director – Analytics, Insights & Decision Enablement (US) at Novartis, as part of the Novartis Global Capability...
With extensive experience across commercial excellence, analytics, insights, AI-driven...
Will President Trump’s Diktat Improve Drug Quality For Indian Patients?
Executive Summary
The geopolitical landscape of pharmaceutical manufacturing is shifting...
Mounjaro is the Exceptional Growth Story: Ranks #1
The July Brand Monitor by Pharmarack shows a healthy...
Sun Pharma: In the Eye of the Storm of Ophthalmologists
The Two-Tier Reality of Indian Pharma: Patient Safety, Pharmacovigilance,...
Kailash Joshi has been appointed as Executive Director – Analytics, Insights & Decision Enablement (US) at Novartis, as part of the Novartis Global Capability...
With extensive experience across commercial excellence, analytics, insights, AI-driven...
Will President Trump’s Diktat Improve Drug Quality For Indian Patients?
Executive Summary
The geopolitical landscape of pharmaceutical manufacturing is shifting...
Mounjaro is the Exceptional Growth Story: Ranks #1
The July Brand Monitor by Pharmarack shows a healthy...
Sun Pharma: In the Eye of the Storm of Ophthalmologists
The Two-Tier Reality of Indian Pharma: Patient Safety, Pharmacovigilance,...
Kailash Joshi has been appointed as Executive Director – Analytics, Insights & Decision Enablement (US) at Novartis, as part of the Novartis Global Capability...
With extensive experience across commercial excellence, analytics, insights, AI-driven...
Hot topics
Pharma Marketing in the New Age
Inside this Issue
1. Conference Notes: Pharma Marketing in the New...
A Tale of Two Companies – Sun Pharma’s Odyssey and Organon’s Second Act
Sun Pharma’s Odyssey and Organon’s Second Act – And...
The Semaglutide Paradox: Anatomy of a High-Stakes Commodity Trap
The Semaglutide Shift: From Blockbuster to Commodity
Why the $50...
Healthcare + Hospitality: India’s Next Big Export
Why Indian hospitals must go beyond treatment to build...
Inspirational Frontline Leadership
The last issue of 2016, with articles from K. Hariram and Vivek Hattangadi and new authors, Dr. Ashwin Bonde and Diksha Fouzdar. Diksha's article is the highlight of this issue - an in-depth look at how to embed compliance in the very DNA of a pharma company.
Will President Trump’s Diktat Improve Drug Quality For Indian Patients?
Executive Summary
The geopolitical landscape of pharmaceutical manufacturing is shifting...
Mounjaro is the Exceptional Growth Story: Ranks #1
The July Brand Monitor by Pharmarack shows a healthy...
Sun Pharma: In the Eye of the Storm of Ophthalmologists
The Two-Tier Reality of Indian Pharma: Patient Safety, Pharmacovigilance,...
Kailash Joshi has been appointed as Executive Director – Analytics, Insights & Decision Enablement (US) at Novartis, as part of the Novartis Global Capability...
With extensive experience across commercial excellence, analytics, insights, AI-driven...
Will President Trump’s Diktat Improve Drug Quality For Indian Patients?
Executive Summary
The geopolitical landscape of pharmaceutical manufacturing is shifting...
Mounjaro is the Exceptional Growth Story: Ranks #1
The July Brand Monitor by Pharmarack shows a healthy...
Sun Pharma: In the Eye of the Storm of Ophthalmologists
The Two-Tier Reality of Indian Pharma: Patient Safety, Pharmacovigilance,...
Kailash Joshi has been appointed as Executive Director – Analytics, Insights & Decision Enablement (US) at Novartis, as part of the Novartis Global Capability...
With extensive experience across commercial excellence, analytics, insights, AI-driven...
Will President Trump’s Diktat Improve Drug Quality For Indian Patients?
Executive Summary
The geopolitical landscape of pharmaceutical manufacturing is shifting...
Mounjaro is the Exceptional Growth Story: Ranks #1
The July Brand Monitor by Pharmarack shows a healthy...
Sun Pharma: In the Eye of the Storm of Ophthalmologists
The Two-Tier Reality of Indian Pharma: Patient Safety, Pharmacovigilance,...
Kailash Joshi has been appointed as Executive Director – Analytics, Insights & Decision Enablement (US) at Novartis, as part of the Novartis Global Capability...
With extensive experience across commercial excellence, analytics, insights, AI-driven...
Will President Trump’s Diktat Improve Drug Quality For Indian Patients?
Executive Summary
The geopolitical landscape of pharmaceutical manufacturing is shifting...
Mounjaro is the Exceptional Growth Story: Ranks #1
The July Brand Monitor by Pharmarack shows a healthy...
Sun Pharma: In the Eye of the Storm of Ophthalmologists
The Two-Tier Reality of Indian Pharma: Patient Safety, Pharmacovigilance,...
Kailash Joshi has been appointed as Executive Director – Analytics, Insights & Decision Enablement (US) at Novartis, as part of the Novartis Global Capability...
With extensive experience across commercial excellence, analytics, insights, AI-driven...
MedicinMan was launched in 2011 as India’s 1st Magazine dedicated to the cause of Field Force Excellence in Pharma and Devices.
Read More
Headlines
Will President Trump’s Diktat Improve Drug Quality For Indian Patients?
Executive Summary
The geopolitical landscape of pharmaceutical manufacturing is shifting...
Mounjaro is the Exceptional Growth Story: Ranks #1
The July Brand Monitor by Pharmarack shows a healthy...
Sun Pharma: In the Eye of the Storm of Ophthalmologists
The Two-Tier Reality of Indian Pharma: Patient Safety, Pharmacovigilance,...
Newsletter
Get important news delivered directly to your inbox and stay connected!